Effects of gut microflora on pharmacokinetics of hesperidin: A study on non-antibiotic and pseudo-germ-free rats

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 73, Issue 21-22, 2010, Pages 1441-1450

  Jin, Ming Ji ^a   Kim, Unyong ^a,b   Kim, In Sook ^a   Kim, Yuri ^c   Kim, Dong Hyun ^c,d   Han, Sang Beom ^b   Kwon, Oh Seung ^a   Yoo, Hye Hyun ^e  

^a Korea Institute of Science and Technology   (South Korea)

^b Chung Ang University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Yuyu Pharma Inc   (South Korea)

^e Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA RHAMNOSIDASE; ANTIBIOTIC AGENT; BETA GLUCOSIDASE; DRUG METABOLITE; ENZYME; ERIODICTYOL; GLUCURONIDE; HEMOERIODICTYOL; HESPERETIN; HESPERETIN GLUCURONIDE; HESPERIDIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FECES LEVEL; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG URINE LEVEL; ENZYME ACTIVITY; FECES MICROFLORA; GERMFREE ANIMAL; INTESTINE FLORA; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; DRUG EFFECTS; ENTEROBACTERIACEAE; ENZYMOLOGY; FECES; INTESTINE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

CITRUS; RATTUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-GLUCOSIDASE; ENTEROBACTERIACEAE; FECES; GERM-FREE LIFE; HESPERIDIN; INTESTINES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77958157551     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2010.511549     Document Type: Article

References (26)

1. Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A., and Rouseff, R. L. 1996. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin. Pharmacol. Ther. 60:34-40.
2. Booth, A. N., Jones, F. T., and Deeds, F. 1958. Metabolic fate of hesperidin, eriodictyol, homoeridictyol, and diosmin. J. Biol. Chem. 230:661-668.
3. Chiba, H., Uehara, M., and Wu, J. 2003. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J. Nutr. 133:1892-1897.
4. Choudhury, R., Srai, S. K., Debnam, E., and Rice-Evans, C. A. 1999. Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radical Biol. Med. 27:278-286.
5. Emim, J. A., Oliveira, A. B., and Lapa, A. J. 1994. Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid, hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice. J. Pharm. Pharmacol. 46:118-122.
6. Felgines, C., Texler, O., Morand, C., Manach, C., Scalbert, A., Régérat, F., and Rémésy, C. 2000. Bioavailability of the flavanone naringenin and its glycosides in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 279:1148-1154.
7. Galati, E. M., Monforte, M. T., Kirjavainen, S., Forestieri, A. M., Trovato, A., and Tripodo, M. M. 1994. Biological effects of hesperidin, a citrus flavonoid. (Note I): Antiinflammatory and analgesic activity. Farmacologie 40:709-712.
8. Garg, A., Garg, S., Zaneveld, L. J. D., and Singla, A. K. 2001. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother. Res. 15:655-669.
9. Griffiths, L. A., and Borrow, A. 1972. Metabolism of flavonoid compounds in germ-free rats. Biochem. J. 130:1161-1162.
10. Guzmán-Gutiérrez, S. L., and Navarrete, A. 2009. Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers. Planta Med. 75:295-301.
11. Hackett, A. M., Marsh, I., Barrow, A., and Griffiths, L. A. 1979. The biliary excretion of flavanones in the rat. Xenobiotica 9:491-501
12. Kawaguchi, K., Kikuchi, S., Hasunuma, R., Maruyama, H., Yoshikawa, T., and Kumazawa, Y. 2004. A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice. Biol. Pharm. Bull. 27:679-683. (Pubitemid 41694670)
13. Kim, Y. S., Kim, J. J., Cho, K. H., Jung, W. S., Moon, S. K., Park, E. K., and Kim, D. H. 2008. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J. Microbiol. Biotechnol. 18:1109-1114.
14. King, L. C., Kohan, M. J., George, S. E., Lewtas, J., and Claxton, L. D. 1990. Metabolism of 1-nitropyrene by human, rat, and mouse intestinal flora: Mutagenicity of isolated metabolites by direct analysis of HPLC fractions with a microsuspension reverse mutation assay. J. Toxicol. Environ. Health 31:179-192.
15. Lee, D. S., Kim, Y. S., Ko, C. N., Cho, K. H., Bae, H. S., Lee, K. S., Kim, J. J., Park, E. K., and Kim, D. H. 2002. Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res. 25:165-169.
16. Loscalzo, L. M., Wasowski, C., Paladini, A. C., and Marder, M. 2008. Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. Eur. J. Pharmacol. 580:306-313.
17. Manach, C., Morand, C., Gil-Izquierdo, A., Bouteloup-Demange, C., and Remesy, C. 2003. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr. 57:235-242.
18. Manning, B. W., Cerniglia, C. E., and Federle, T. W. 1986. Biotransformation of 1-nitropyrene to 1-aminopyrene and N-formyl-1-aminopyrene by the human intestinal microbiota. J. Toxicol. Environ. Health 18:339-346.
19. Matsumoto, H., Ikoma, Y., Sugiura, M., Yano, M., and Hasegawa, Y. 2004. Identification and quantification of the conjugated metabolites derived from orally administred hesperidin in rat plasma. J. Agric. Food Chem. 52:6653-6659.
20. Monforte, M. T., Trovato, A., Kirjavainen, S., Forestieri, A. M., Galati, E. M., and Lo Curto, R. B. 1995. Biological effects of hesperidin, a Citrus flavonoid. (Note II): Hypolipidemic activity on experimental hypercholesterolemia in rat. Farmacologie 50:595-599.
21. Morehead, M. C., Franklin, W., Fu, P. P., Evans, F. E., Heinze, T. M., and Cerniglia, C. E. 1994. Metabolism of 7-nitrobenz[a]anthracene by intestinal microflora. J. Toxicol. Environ. Health 43:369-380.
22. Nielsen, S. E., Breinholt, V., Justesen, U., Cornett, C., and Dragsted, L. O. 1998. In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 28:389-401.
23. Ohtsuki, K., Abe, A., and Mitsuzumi, H. 2003. Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature. J. Nutr. Sci. Vitaminol. 49:447-450.
24. Park, S. H., Park, E. K., and Kim, D. H. 2005. Passive cutaneous anaphylaxisinhibitory activity of flavanones from citrus unshiu and Poncirus trifoliata. Planta Med. 71:24-27.
25. Richardson, K. E., Fu, P. P., and Cerniglia, C. E. 1988. Metabolism of 1-, 3-, and 6-nitrobenzo[a]pyrene by intestinal microflora. J. Toxicol. Environ. Health 23:527-537.
26. Walle, T. 2004. Absorption and metabolism of flavonoids. Free Radical Biol. Med. 36:829-837.